Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $736.6000 (0.12%) ($736.6000 - $737.7300) on Fri. Nov. 25, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.92% (three month average) | RSI | 48 | Latest Price | $736.6000(0.12%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.1% a day on average for past five trading days. | Weekly Trend | REGN declines -0.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(51%) DIA(33%) IWD(29%) SPLV(29%) SDY(28%) | Factors Impacting REGN price | REGN will decline at least -1.46% in a week (0% probabilities). TBT(-16%) URA(-4%) ARKG(-2%) VCSH(-1%) UUP(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.46% (StdDev 2.92%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Resistance Level | $742.25 | 5 Day Moving Average | $739.88(-0.44%) | 10 Day Moving Average | $738.27(-0.23%) | 20 Day Moving Average | $742.25(-0.76%) | To recent high | -3.1% | To recent low | 28.4% | Market Cap | $78.101b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |